FORM 8-K

Company

Compass Therapeutics, Inc.

Filed

March 5, 2026

Period of Report

March 5, 2026

Accession Number

0001171843-26-001336

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →